Following a peak in cases throughout 2022 and 2023, health officials have lifted the public health emergency declaration regarding mpox across the African continent, a move signaling progress in containing the viral outbreak [[1]], [[2]]. The Africa Centres for Disease Control and Prevention initially declared mpox a Public Health Emergency of Continental Security in August 2024 [[3]], prompting a coordinated international response. While the emergency phase has ended, authorities emphasize that mpox remains endemic in several African countries and ongoing vigilance is critical.
Mpox Public Health Emergency Lifted in Africa
The public health emergency declared in response to the mpox outbreak in Africa has been lifted, according to recent reports. This decision reflects a significant decline in cases across the continent, signaling a positive shift in the region’s response to the virus. The lifting of the emergency status is a key step in transitioning from crisis management to long-term control of mpox.
The decision to end the public health emergency was made after a careful assessment of the evolving epidemiological situation. Authorities noted a substantial decrease in reported mpox cases in affected countries. While the virus has not been eradicated, the current situation no longer warrants the heightened emergency measures previously in place.
The outbreak, which gained international attention in 2022, led to widespread concern and prompted a coordinated global response. The World Health Organization (WHO) initially declared a Public Health Emergency of International Concern (PHEIC) in July 2022, but later downgraded the alert in May 2023. The lifting of the emergency status in Africa follows this global trend.
Despite the positive developments, health officials emphasize the importance of continued vigilance and sustained public health efforts. Ongoing surveillance, vaccination programs, and awareness campaigns remain crucial to prevent future outbreaks and protect vulnerable populations. The focus now shifts to integrating mpox control measures into existing healthcare systems for a more sustainable approach.
The decline in cases is attributed to a combination of factors, including increased vaccination coverage, improved surveillance systems, and behavioral changes among at-risk populations. However, experts caution that mpox remains a potential threat, and continued monitoring is essential to detect and respond to any resurgence of the virus.
